Sepsis Mortality Score Using Multi-Marker Approach for the Prediction of Mortality in Septic Critically Ill Patients
Introduction: Clinical scoring methods such as the Sequential Organ Failure Assessment (SOFA) score are frequently used to predict outcome in sepsis, with limited capacity. Further tools for risk assessment of septic critically ill patients would thus be useful. Our purpose was to derive a scoring method i.e. Sepsis Mortality Score using multimarker approach for the prediction of 30-day mortality in septic critically ill patients, and compare its performance to the SOFA score. Materials and method: This prospective study included 159 septic patients admitted to an intensive care unit (ICU). Leukocytes count, procalcitonin (PCT), interleukin-6 (IL-6), paraoxonase (PON) and arylesterase (ARE) were assayed from blood draws obtained on ICU presentation. Logistic regression was used to identify an optimal combination of these biomarkers to create the Sepsis Mortality Score, which was the predicted probability of 30-day mortality. Results: The 30-day mortality rate was 28.9%. In the logistic regression model, leukocytes count, PCT, IL-6 and ARE remained as independent biomarkers. The areas under curve (AUC) of the Sepsis Mortality Score derived from these biomarkers was 0.814 (95% confidence interval (CI) 0.736-0.892), better than the SOFA score (AUC 0.767 (95% CI 0.677-0.857). Addition of Sepsis Mortality Score on SOFA score showed an even better prediction of 30-day mortality (AUC 0.845 (95% CI 0.772-0.919)). Conclusion: Multi-marker approach using leukocytes count, PCT, IL-6 and ARE, combined with the SOFA score, might provide a valuable tool for risk assessment of septic critically ill patients.
How to Cite
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.